Limited research exists on how speech impairments affect quality of life (QOL) factors over time in patients with amyotrophic lateral sclerosis (ALS). A review of the literature, including the history, disease course, and prevalence of ALS, is presented. Physical and psychosocial functioning, especially the decline of bulbar functioning’s potential impact on QOL factors and communication style, are outlined. This study is a follow-up study on a study by Duff, who found a significant difference in QOL relative to level of bulbar functioning in a cross-sectional design. The current study used a longitudinal design to look at bulbar functioning, specifically levels of speech, and how that affects certain aspects of QOL over time. This study us...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes muscle we...
Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by sy...
There is no cure for the fatal progression of Amyotrophic Lateral Sclerosis (ALS). Optimization of q...
The purpose of this study was to examine the self-perceived QOL in ALS patients. Literature will be ...
Concurrent with the well-documented motor speech production impairments in amyotrophic lateral scler...
Global quality of life (QoL) in patients with ALS has been found to be independent of overall physic...
Objective: to analyze the scientific evidence that evaluated the quality of life of patients with Am...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
People with amyotrophic lateral sclerosis (ALS) often experience changes to their speech, and may us...
This Research Watch Report focuses on current research on quality of life among individuals with amy...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor ne...
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a progressive neurodegenerative dis...
Living with amyotrophic lateral sclerosis (ALS) is a complex and difficult experience that necessita...
Background: The absence of curative medication for amyotrophic lateral sclerosis (ALS) makes palliat...
Amyotrophic Lateral Sclerosis (ALS) is the most common progressive and fatal neurodegenerative disea...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes muscle we...
Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by sy...
There is no cure for the fatal progression of Amyotrophic Lateral Sclerosis (ALS). Optimization of q...
The purpose of this study was to examine the self-perceived QOL in ALS patients. Literature will be ...
Concurrent with the well-documented motor speech production impairments in amyotrophic lateral scler...
Global quality of life (QoL) in patients with ALS has been found to be independent of overall physic...
Objective: to analyze the scientific evidence that evaluated the quality of life of patients with Am...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
People with amyotrophic lateral sclerosis (ALS) often experience changes to their speech, and may us...
This Research Watch Report focuses on current research on quality of life among individuals with amy...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor ne...
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a progressive neurodegenerative dis...
Living with amyotrophic lateral sclerosis (ALS) is a complex and difficult experience that necessita...
Background: The absence of curative medication for amyotrophic lateral sclerosis (ALS) makes palliat...
Amyotrophic Lateral Sclerosis (ALS) is the most common progressive and fatal neurodegenerative disea...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes muscle we...
Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by sy...
There is no cure for the fatal progression of Amyotrophic Lateral Sclerosis (ALS). Optimization of q...